Montanari Linda, Guarita Bruno, Mounteney Jane, Zipfel Nina, Simon Roland
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisboa, Portugal.
Eur Addict Res. 2017;23(3):113-121. doi: 10.1159/000475810. Epub 2017 May 17.
This paper explores European and national trends in specialised drug treatment entry for cannabis-related problems. The analysis is based on data for the years 2003-2014 from 22 European countries. Between 2003 and 2014, the overall number and proportion of primary cannabis-related first-time entrants increased significantly. A joinpoint regression analysis indicates that the overall increase of cannabis treatment entries is continuous, although country-related differences are observed. Possible explanations for the increase and different time trends are discussed including an increase in cannabis prevalence and cannabis-related problems, changes in risk perception, increases in cannabis potency, changes in referral practices and increased availability and accessibility of treatment services.
本文探讨了欧洲及各国针对大麻相关问题进行专业药物治疗的趋势。该分析基于2003年至2014年来自22个欧洲国家的数据。2003年至2014年间,与大麻相关的首次接受治疗的主要患者总数及比例显著增加。连接点回归分析表明,大麻治疗患者总数的增长是持续的,尽管存在国家间差异。文中讨论了增长及不同时间趋势的可能解释,包括大麻流行率及相关问题的增加、风险认知的变化、大麻效力的增强、转诊方式的改变以及治疗服务可获得性和可及性的提高。